Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/IRCT20210424051066N1
IRCT20210424051066N1RecruitingPhase 4

Comparison of the efficacy of sertraline, escitalopram in treatment of depression in patients undergoing chronic hemodialysis

Shahid Beheshti University of Medical Sciences0 sites132 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 4
Status
Recruiting
Enrollment
132
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
21 years to no limit (—)
Sex
All

Inclusion Criteria

  • •Depression in chronic hemodialysis patients
  • •consent for study participation
  • •Age above 21

Exclusion Criteria

  • •another psychologic problems in patients
  • •no drug compliance because of drug side effects
  • •data defects
  • •patients undergo another treatments
  • •patients with no follow up

Investigators

Similar Trials

Recruiting
Phase 3
Comparison of the effectiveness of sertraline and Nortriptyline on anxiety and gastrointestinal symptoms in patients with irritable bowel syndromeIrritable bowel syndrome
IRCT20190618043934N13Birjand University of Medical Sciences192
Completed
Phase 3
Sertraline and Fluoxetin in Diabetic Patients with DepressioDiabetes Mellitus.Diabetes mellitus due to underlying condition
IRCT20150630022991N9Babol University of Medical Sciences40
Recruiting
Phase 2
Evaluation of effectiveness of Sertraline and supportive psychotherapy on anxiety and depression level
IRCT20180425039418N4Zahedan University of Medical Sciences60
Not yet recruiting
Phase 2
Comparison of the effect of sertraline and midodrine in improving blood pressure during hemodialysisHypotension of hemodialysis.Hypotension of hemodialysisI95.3
IRCT20100102002954N29Shahroud University of Medical Sciences82
Recruiting
Not Applicable
Comparison of therapeutic effect of sertraline and supportive psychotherapy in comparison with placebo in coronary heart disease patients with mild to moderate depressioCondition 1: Depression. Condition 2: Mild Depression. Condition 3: Moderate depression.F32 Depressive episode In typical mild, moderate, or severe depressive episodes, the patient suffers from lowering of mood, reduction of energy, and decrease in activity. Capacity for enjoyment, interest, and concentration is reduced, and marked tireF32.0 Mild depressive episode Two or three of the above symptoms are usually present. The patient is usually distressed by these but will probably be able to continue with most activities.F32.1 Moderate depressive episode Four or more of the above symptoms are usually present and the patient is likely to have great difficulty in continuing with ordinary activities.
IRCT20171105037241N2Zahedan University of Medical Sciences90